Improving access to genetic testing in epithelial ovarian cancer

Ovarian cancer is the fifth commonest cause of cancer-related mortality in women, with over 7000 women diagnosed with the disease in the UK each year. A proportion of cases (around 15-20%) are caused by inherited mutations, with mutations in th e BRCA1 and BRCA2 genes being the most common. Knowledge of a woman’s mutation status can inform treatment options as certain classes of drug...